The following Structured Product Label (SPL) was submitted to the FDA by Bm Private Limited for the product Bm Homoeolax (NDC 85816-6031). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding otc - active ingredient, indications & usage, otc - purpose, dosage & administration, warnings, otc - keep out of reach of children, inactive ingredient, package label.principal display panel, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Active Ingredients (Ref. Standards)
Each tablet contains:
Aloes soco D6 — 0.001 mg (HPUS)
Alumen D3 — 0.001 mg (HPUS)
Bryonia D7 — 0.001 mg (HPUS)
Croton tig D7 — 0.0001 mg (HPUS)
Hydrastis can D5 — 0.001 mg (HPUS)
Mag mur D3 — 0.1 mg (HPUS)
Phenolphthalein D2 — 60 mg (EHPI)
Indications
Help support to relieve the symptoms of acute and habitual constipation. For detail please read the enclosed package (product information leaflet).
Indications
Help support to relieve the symptoms of acute and habitual constipation. For detail please read the enclosed package (product information leaflet).
Dosage
Adult: Two tablets at bedtime.
Teenager: Half of the same.
Precautions / Storage
Keep away from children and store at a cool and dry place
Precautions / Storage
Keep away from children and store at a cool and dry place
Potato Starch, Dicalcium Phosphate Anhydrous, Microcrystalline Cellulose, Lactose Monohydrate, Povidone K-30, Magnesium Stearate, Silicon Dioxide, Hypromellose, Polyethylene Glycol, Titanium Dioxide, FD&C Yellow No. 5, Carmoisine.
* Please review the disclaimer below.
